PHAT vs REGN: Which Stock is Better?

Side-by-side comparison of Phathom Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

PHAT

Phathom Pharmaceuticals Inc

$13.19

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricPHATREGNWinner
Market Cap$1.00B$78.87BREGN
P/E RatioN/A17.98REGN
EPS (TTM)$N/A$41.48REGN
Revenue Growth0.9%0.0%PHAT
Gross Margin87.1%44.6%PHAT

Analyze PHAT

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is PHAT or REGN a better investment?

Comparing PHAT and REGN: Phathom Pharmaceuticals Inc has a market cap of $1.00B while Regeneron Pharmaceuticals Inc has $78.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between PHAT and REGN?

PHAT (Phathom Pharmaceuticals Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: PHAT or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: PHAT or REGN?

PHAT has higher revenue growth at 0.9% vs 0.0% for REGN.

Which company is more profitable: PHAT or REGN?

Phathom Pharmaceuticals Inc (PHAT) has higher gross margins at 87.1% compared to 44.6% for REGN.

Which is the larger company: PHAT or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.87B compared to $1.00B for PHAT.

Should I buy PHAT or REGN in 2026?

Both PHAT and REGN have investment merit. PHAT trades at $13.19 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between PHAT and REGN stock?

Key differences: Market Cap ($1.00B vs $78.87B), P/E Ratio (N/A vs 18.0x), Revenue Growth (0.9% vs 0.0%), Gross Margin (87.1% vs 44.6%).

Popular Stock Comparisons